Statistics from Altmetric.com
What is the clinical efficacy of high frequency repetitive transcranial magnetic stimulation in people with treatment resistant depression?
The primary outcome was clinical response defined using a global rating scale (eg, “much improved” or “very much improved” on the Clinical Global Impression Scale (CGI)) or a set level of improvement on a continuous depression rating scale (eg, improvement of 50% or greater from baseline to end of treatment on the Hamilton Depression Rating Scale (HAMD) or the Montgomery–Asberg Depression Rating Scale (MADRS)). Secondary outcomes included depressive symptoms (end point symptom scores) and remission (defined as a score on a depression rating scale within the normal range—eg, HAMD score ⩽7, MADRS score ⩽12 or …
Source of funding: Not stated.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.